细胞膜工程策略用于临床指导的纳米医学设计
Di Huang1, Xiaoyu Wang1, Wentao Wang1
1College of Science, State Key Laboratory of Tree Genetics and Breeding, Nanjing Forestry University, Nanjing 210037, P. R. China. xiabing@njfu.edu.cn.
Biomaterials science
|April 30, 2024
概括
细胞膜涂层通过利用自然细胞膜特性来增强纳米医学. 这些膜的工程提供了多样化的治疗功能,并克服了免疫系统的清除,以改善临床应用.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术 纳米技术
- 细胞生物学 细胞生物学
背景情况:
- 细胞膜定义了细胞边界,并促进了重要功能.
- 纳米医学看起来很有前途,但面临着免疫系统清除挑战.
- 细胞膜涂层通过提高纳米医药的生物相容性和有效性提供了一个解决方案.
研究的目的:
- 审查细胞膜涂层纳米药物的临床应用和治疗机制.
- 概述目前用于细胞膜修饰的工程策略.
- 讨论细胞膜涂层技术的局限性和未来解决方案.
主要方法:
- 在纳米医学中细胞膜涂层的文献综述.
- 工程方法 (化学,物理,生物) 的分析.
- 临床应用和治疗机制的评估.
主要成果:
- 细胞膜涂层通过提高生物相容性和隐形性质来提高纳米药物的有效性.
- 工程细胞膜可以实现对复杂疾病的多功能治疗功能.
- 总结了四种典型的细胞膜及其应用.
结论:
- 细胞膜涂层是克服纳米医学局限性的有希望的策略.
- 进一步的工程和解决临床挑战对于广泛采用至关重要.
- 这项技术对未来的纳米医药开发具有重大潜力.
更多相关视频
10:16Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier
Published on: February 8, 2017
7.6K
06:57Rapid, Scalable Assembly and Loading of Bioactive Proteins and Immunostimulants into Diverse Synthetic Nanocarriers Via Flash Nanoprecipitation
Published on: August 11, 2018
7.9K
相关概念视频
Modified-Release Drug Delivery Systems: Site-Targeted
167
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
167
Site-Targeted Drug Delivery Systems: Polymeric Carriers
167
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
167
